Essential Oil+ELA, Plaque and Gingivitis

计划入组 59 人 · 首次发布于 2016 年 8 月 31 日

Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)

计划入组 5 人 · 首次发布于 2018 年 7 月 11 日

Exacerbations and Their Outcomes International (EXACOS International)

计划入组 1,762 人 · 首次发布于 2021 年 6 月 16 日

Fc-ELA-32

ELA-026

Fc-ELA-21

Ela Medical Inc

United States

SORIN CRM SAS

France

Elan Pharma International Ltd.

United States

SETU Secures €159,589 Grant for Novel Gene Therapy Research in Fatal Childhood Canavan Disease

EMA's CHMP Recommends 10 New Medicines, Including Novel Therapies and Biosimilars

Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Trials to the UK